Joined May 2020
October 20, 2021
Management and outcome of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hyper...
Margitta Worm, A. Alexiou, Andrea Bauer, et al.
June 24, 2021
COVID-19-vaccination in patients receiving allergen immunotherapy (AIT) or biologics...
Marek Jutel, María José Torres, Oscar Palomares, et al.
February 18, 2021
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis w...
Ioana Agache, Yang Song, Pablo Alonso-Coello, et al.
January 01, 2021
Allergenic components of the mRNA-1273 vaccine for COVID-19: possible involvement of...
Ludger Klimek, Natalija Novak, Beatriz Cabanillas, et al.
January 15, 2021
Allergen immunotherapy: the growing role of observational and randomised trial “real-...
Giovanni Paoletti, Danilo Di Bona, Derek Chu, et al.
December 28, 2020
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines -- an EAACI-AR...
Ludger Klimek, Marek Jutel, Cezmi Akdis, et al.
August 26, 2020
Heterogeneity of the pharmacologic treatment of allergic rhinitis in Europe based on...
Jean Bousquet, Detlef Schroder-Bernhardi, Claus Bachert, et al.
May 29, 2020
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
CARMEN RIGGIONI, Pasquale Comberiati, Mattia Giovannini, et al.